- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Profitable Climbers
Taiwanese Pharmaceuticals & Biotech Profitable Climbers
Results
3
0 new
3 companies
Bora Pharmaceuticals
Market Cap: NT$56.1b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$459.50
7D
-5.3%
1Y
-29.7%
PharmaEssentia
Market Cap: NT$247.6b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$671.00
7D
-2.8%
1Y
34.2%
Lotus Pharmaceutical
Market Cap: NT$66.7b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$260.00
7D
-3.0%
1Y
-0.4%